Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.31 USD | -1.93% | +6.83% | -14.68% |
05-08 | Stifel Adjusts Price Target on Denali Therapeutics to $22 From $26, Maintains Hold Rating | MT |
05-08 | Wedbush Adjusts Denali Therapeutics' Price Target to $30 From $31, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.68% | 2.61B | |
+3.91% | 109B | |
+10.87% | 105B | |
-0.15% | 22.25B | |
-13.14% | 22.09B | |
-8.00% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- DNLI Stock
- News Denali Therapeutics Inc.
- Earnings Flash (DNLI) DENALI THERAPEUTICS Reports Q3 Revenue $1.3M